Keywords: |
cancer chemotherapy; review; erlotinib; drug efficacy; nonhuman; drug targeting; molecular genetics; antineoplastic agent; neoplasm; neoplasms; animal; animals; gene targeting; imatinib; metastasis; gene expression profiling; protein targeting; genetic transcription; transcription, genetic; antineoplastic activity; drug effect; diagnostic imaging; protein tyrosine kinase inhibitor; gene mapping; drug mechanism; isotope labeling; messenger rna; three dimensional imaging; imaging, three-dimensional; gefitinib; gene therapy; reporter gene; nuclear medicine; genes, reporter; immunofluorescence test; molecular biology; tumor vascularization; non invasive measurement; quinazoline derivative; genetic marker; genetic markers; gastrointestinal carcinoma; humans; human; priority journal
|